Semaglutide ( n = 4, SUSTAIN-6 [14], PIONEER-6 [15], SELECT [8], SOUL [16])
Preclinical data on GLP-1 and GLP-1 RAs have displayed an impressive neuroprotective efficacy in stroke, Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases
Rather than paying an assessment, the City of Austin contributes $360,000 annually for City-owned properties within DPID boundaries
Jilin Provincial Natural Science Foundation General Project (Grant NO.YDZJ202301ZYTS102)
GLP-1 receptor agonistsmedications such as semaglutide and liraglutidehave gained attention for their weight management properties, though they were originally developed for type 2 diabetes
Mitochondrial malfunction plays a crucial role in cardiac metabolic remodeling